// App-Quantinova.ai

139 : Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism

Researchers

Presenter

  • Philip S Wells

Principal Investigators

  • Michael J. Kovacs

  • David Anderson

  • Susan R. Kahn

  • Clive Kearon

  • Sam Schulman

  • David M. Keeling

  • Scott Kaatz

  • Susan Solymoss

  • Daniel Corsi

  • Marc Rodger

Medical Centers

  • Centre for Clinical Epidemiology, Jewish General Hospital, Montreal, QC, Canada

  • Department of Medicine, Division of Hematology, London Health Sciences Centre, London, ON, Canada

  • McMaster University, Hamilton, ON, Canada

  • Henderson Hospital, McMaster University Clinic, Hamilton, ON, Canada

  • Department of Oncology, McGill University, Montreal, QC, Canada

  • Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON, Canada

  • The Ottawa Hospital, Ottawa, ON, Canada

  • Dalhousie University, Halifax, Nova Scotia, Canada.

  • Hurley Medical Center, Flint, MI

  • University of Ottawa, Ottawa, ON, Canada

  • Department of Medicine, University of Ottawa, Ottawa, ON, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved